
Academic Journal
Q2Australian Prescriber
About Australian Prescriber
About Australian Prescriber
Australian Prescriber is a peer-reviewed scholarly journal published by 3299 (Australia). It focuses on Q2. Publication coverage spans 1995-2026.
Key indicators: ISSN 0312-8008, 1839-3942; H-index 50.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (50): Strong citation impact — 50 articles cited at least 50 times each, reflecting solid influence.
Publishing in Australian Prescriber
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q2. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Australian Prescriber?
0312-8008, 1839-3942.
Who publishes Australian Prescriber?
3299.
What are Australian Prescriber's metrics?
H-index 50.
Where do I submit to Australian Prescriber?
Via the official website.
Is Australian Prescriber peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2023-09-21. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Pharmaceutical Economics and Policy; Pharmaceutical studies and practices; Cancer Treatment and Pharmacology; Pharmaceutical Practices and Patient Outcomes; Pharmaceutical industry and healthcare; Pharmacological Effects and Toxicity Studies.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Website review: Pregnancy and breastfeeding medicines guide
2016-06-01 · DOI: 10.18773/austprescr.2016.034Letter: Anal fissures and liquid paraffin
2016-06-01 · DOI: 10.18773/austprescr.2016.040Editorial: The NPS MedicineWise vision for Australian Prescriber
2016-06-01 · DOI: 10.18773/austprescr.2016.042Switching and stopping antidepressants
2016-06-01 · DOI: 10.18773/austprescr.2016.039Where to find information about drugs
2016-06-01 · DOI: 10.18773/austprescr.2016.023Book review: Paediatric emergency medication book
2016-06-01 · DOI: 10.18773/austprescr.2016.036Diagnostic Tests: Secondary osteoporosis
2016-06-01 · DOI: 10.18773/austprescr.2016.038Dental note: Drug-seeking behavior
2016-06-01 · DOI: 10.18773/austprescr.2016.029Dental note: Oral and dental effects of antidepressants
2016-06-01 · DOI: 10.18773/austprescr.2016.035Letter: Metformin and patients on dialysis
2016-06-01 · DOI: 10.18773/austprescr.2016.041Editorial: The challenge of costly drugs
2016-06-01 · DOI: 10.18773/austprescr.2016.037Comment: Farewell to print
2016-06-01 · DOI: 10.18773/austprescr.2016.043Dealing with drug-seeking behaviour
2016-06-01 · DOI: 10.18773/austprescr.2016.022New drugs: Ceftolozane sulfate with tazobactam sodium for specified infections
2016-06-01 · DOI: 10.18773/austprescr.2016.044Comment: Meldonium and the WADA Prohibited List
David Hughes
2016-06-01 · DOI: 10.18773/austprescr.2016.032Diagnostic Tests: Bone mineral density: testing for osteoporosis
Angela Sheu, Terry Diamond
2016-04-01 · DOI: 10.18773/austprescr.2016.020Prescribing and borderline personality disorder
Andrew M Chanen, Katherine N Thompson
2016-04-01 · DOI: 10.18773/austprescr.2016.019Warfarin and beetroot
John Raven, Philip A Tideman, Rosy Tirimacco, Andrew St John et al.
2016-04-01 · DOI: 10.18773/austprescr.2016.017Dental note: Osteoporosis treatment and medication-related osteonecrosis of the jaws
Christopher Daly
2016-04-01 · DOI: 10.18773/austprescr.2016.026Benzodiazepines
Kevin McNamara, Bridin Murnion, Jonathan Brett
2016-04-01 · DOI: 10.18773/austprescr.2016.016Reviews
Community Reviews
Version History
October 10, 2026 at 1:15 am
October 2, 2026